Home > Healthcare > Medical Services > Surgical Services > aesthetic medicine market
Get a free sample of Aesthetic Medicine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Aesthetic Medicine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The aesthetic medicine industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive aesthetic products with improved efficiency and affordability. This includes advancements in design, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
Some of the eminent market participants operating in the aesthetic medicine industry include:
U.S. aesthetic medicine market size is anticipated to grow at 11.4% CAGR during 2024 to 2032 owing to a large population with a significant demand for aesthetic procedures and treatments.
Apax Partners, Bausch Health Companies Inc, El.En. S.p.A., GC Aesthetics plc, Huadong Medicine Co., Ltd, Johnson & Johnson, Merz Pharma, Sciton, Inc., SharpLight Technologies Inc., and Sisram Medical Ltd among others.
The non-surgical procedures type segment held decent share of the aesthetic medicine industry in 2023 and is estimated to account for USD 41.8 billion by 2032, as they are more affordable than surgical interventions.
The aesthetic medicine market size was valued at USD 19.2 billion in 2023 and is estimated to grow at 12% CAGR from 2024 to 2032, driven by growing awareness of aesthetic procedures.